If you look hard enough, you will find these “admissions of guilt” all over the internet. I’m not talking about Conservative websites – I’m speaking of NIH and Hospitals and those who pushed the jabs as ‘safe.’ And the list includes the Washington Post.
I am a hyper-alleric person. I won’t bore you with the foods and vitamins and medicines which have forced me to take my epipen, but let’s just say that eating or drinking anything new, or taking a new medicine does make me nervous.
When the Jab first came out, my doctor (a Hopkins doc) told me that in light of my terrible allergies he thought that it was best for me to hold off. But as time went on, he began pushing the jab on me, to which I would respond “No thanks.”
“Necessity is the mother of invention:” An adage was brought to life with the emergence of the mRNA vaccine against the backdrop of the foreboding and mercurial COVID-19 pandemic. Considering a negligible adverse-effect profile and a break-neck manufacturing speed, it shone bright as the ideal vaccine candidate. However, “all that glitters is not gold,” as was evidenced by the significant reactogenicity, a host of multi-systemic side-effects, that are being reported by the vaccine recipients; which is palpably resulting in a shift of emotions for the vaccine, accounting for vaccine hesitancy. Anaphylaxis, antibody-dependent enhancements, and deaths, comprise the most serious side-effects, albeit occurring in sparing numbers. Storage and transportation require fastidious temperatures, rendering it substantially inaccessible to a country like India. The biggest jolt, however, was the unfolding of the biases in reporting vaccine efficacy, as only the attractively high numbers of the relatively equivocal relative risk reduction were reported while keeping at bay the meager numbers of the more forthright absolute risk reduction. Notwithstanding the fallacies, the mRNA vaccine still promises hope; and with the right precautions and finesse, can be potentiated, as “a watched pot never boils.”
Keywords: Absolute risk reduction; BioNTech; COVID-19; mRNA vaccine; moderna; pfizer; reactogenicity; relative risk reduction; vaccine; vaccine hesitancy.
Copyright: © 2021 Industrial Psychiatry Journal.
Conflict of interest statement
There are no conflicts of interest.
- COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.Meo SA, Bukhari IA, Akram J, Meo AS, Klonoff DC.Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.PMID: 33629336 Review.
- Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices – United States, July 2021.Rosenblum HG, Hadler SC, Moulia D, Shimabukuro TT, Su JR, Tepper NK, Ess KC, Woo EJ, Mba-Jonas A, Alimchandani M, Nair N, Klein NP, Hanson KE, Markowitz LE, Wharton M, McNally VV, Romero JR, Talbot HK, Lee GM, Daley MF, Mbaeyi SA, Oliver SE.MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1094-1099. doi: 10.15585/mmwr.mm7032e4.PMID: 34383735 Free PMC article.
- Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine – United States, December 14-23, 2020.CDC COVID-19 Response Team; Food and Drug Administration.MMWR Morb Mortal Wkly Rep. 2021 Jan 15;70(2):46-51. doi: 10.15585/mmwr.mm7002e1.PMID: 33444297 Free PMC article.
- Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions – United States, March-August 2021.Self WH, Tenforde MW, Rhoads JP, Gaglani M, Ginde AA, Douin DJ, Olson SM, Talbot HK, Casey JD, Mohr NM, Zepeski A, McNeal T, Ghamande S, Gibbs KW, Files DC, Hager DN, Shehu A, Prekker ME, Erickson HL, Gong MN, Mohamed A, Henning DJ, Steingrub JS, Peltan ID, Brown SM, Martin ET, Monto AS, Khan A, Hough CL, Busse LW, Ten Lohuis CC, Duggal A, Wilson JG, Gordon AJ, Qadir N, Chang SY, Mallow C, Rivas C, Babcock HM, Kwon JH, Exline MC, Halasa N, Chappell JD, Lauring AS, Grijalva CG, Rice TW, Jones ID, Stubblefield WB, Baughman A, Womack KN, Lindsell CJ, Hart KW, Zhu Y, Mills L, Lester SN, Stumpf MM, Naioti EA, Kobayashi M, Verani JR, Thornburg NJ, Patel MM; IVY Network.MMWR Morb Mortal Wkly Rep. 2021 Sep 24;70(38):1337-1343. doi: 10.15585/mmwr.mm7038e1.PMID: 34555004 Free PMC article.
- Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials.Brown RB.Medicina (Kaunas). 2021 Feb 26;57(3):199. doi: 10.3390/medicina57030199.PMID: 33652582 Free PMC article.
- Advances in Circular RNA and Its Applications.Zhao X, Zhong Y, Wang X, Shen J, An W.Int J Med Sci. 2022 May 27;19(6):975-985. doi: 10.7150/ijms.71840. eCollection 2022.PMID: 35813288 Free PMC article. Review.
- Olliaro P, Torreele E, Vaillant M. COVID-19 vaccine efficacy and effectiveness–The elephant (not) in the room. Lancet Microbe. 2021;2:e279–80. – PMC – PubMed
LinkOut – more resources